Date Title Description PDF
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download

Pages

40 / 63
Date Title Description PDF
17 Jun 2026 Announcement of general shareholders’ meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting.  Download
06 May 2026 Announcement of general shareholders’ meeting The Company announces the calling of its 2026 Ordinary General Shareholder´s Meeting. Download
01 Apr 2026 On corporate transactions ROVI announces the closing of the Asset Purchase Agreement entered into in September 2025 for the acquisition of a pharmaceutical manufacturing facility in Phoenix, Arizona (USA) Download
25 Feb 2026 Annual Corporate Governance Report The Company submits the Annual Corporate Governance Report for fiscal year 2025.   Download
25 Feb 2026 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2025 annual report regarding remuneration of the members of the Board of Directors. Download

Pages

5 / 176
Date Title Description PDF
08 Nov 2012 Composición Consejo de Administración Download
18 Sep 2012 Otros sobre negocio y situación financiera Download
26 Jul 2012 Información sobre resultados (2) Download
26 Jul 2012 Información sobre resultados Download
26 Jul 2012 Información financiera intermedia Download

Pages

175 / 194